Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawy produktów leczniczych

The subject of the order includes 32 lots: Lot No. 1: Ipilimumab Lot No. 2: Nivolumab Lot No. 3: Pembrolizumab Lot No. 4: Afatinib Lot No. 5: Nintedanib Lot No. 6: Palbociclib Lot No. 7: Abemaciclib Lot No. 8: Sacituzumab govitecan Lot No. 9: Talazoparib Lot No. 10: Elotuzumab Lot No. 11: Ramucirumab Lot No. 12: Ruxolitinib Lot No. 13: Fedratinib Lot No. 14: Eltrombopag Lot No. 15: Midostaurin Lot No. 16: Azacitidine Lot No. 17: Siltuximab Lot No. 18: Luspaterecept Lot No. 19: Ponatinib Lot No. 20: Venetoclax Lot No. 21: Rucaparib Lot No. 22: Mirvetuximab soravtansine Lot No. 23: Teclistamab Lot No. 24: Talquetamab Lot No. 25: Elranatamab Lot No. 26: Niraparib + Abiraterone Lot No. 27: Momelotinib Lot No. 28: Epkoritamab Lot No. 29: Ivosidenib Lot No. 30: rADAMTS13 Lot No. 31: Apalutamide Lot No. 32: Rasburicase